Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
May 7, 2013 yancopoulos george Officer Sell 100,000 261.66 - 264.21
May 6, 2013 yancopoulos george Officer Option Execute 192,308 13.00
May 6, 2013 yancopoulos george Officer Disposition (Non Open Market) 103,243 260.44
Dec 19, 2012 yancopoulos george Officer Option Execute 50,846 9.49 - 21.92
Dec 17, 2012 yancopoulos george Officer Option Execute 10,369 109.29
Dec 17, 2012 yancopoulos george Officer Automatic Sell 238,535 179.13
Dec 14, 2012 yancopoulos george Officer Automatic Sell 38,391 179.13
Jun 27, 2012 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
May 1, 2012 yancopoulos george Officer Automatic Sell 33,165 133.95 - 135.29
Mar 26, 2012 yancopoulos george Officer Automatic Sell 33,150 120.21 - 121.09
Feb 15, 2012 yancopoulos george Officer Option Execute 133,332 8.50
Feb 15, 2012 yancopoulos george Officer Disposition (Non Open Market) 67,017 109.29
Jan 5, 2012 yancopoulos george Officer Automatic Sell 27,713 58.00
Dec 14, 2011 yancopoulos george Officer Automatic Sell 38,516 51.18
Dec 1, 2011 yancopoulos george Officer Automatic Sell 27,713 58.86 - 59.45
Nov 30, 2011 yancopoulos george Officer Option Execute 200,000 28.01
Nov 30, 2011 yancopoulos george Officer Automatic Sell 142,722 58.19
Dec 3, 2009 yancopoulos george Officer Option Execute 100,000 8.77
Dec 3, 2009 yancopoulos george Officer Automatic Sell 67,860 19.29
Dec 16, 2008 yancopoulos george Officer Option Execute 100,000 7.41
Showing 1-20 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)